loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-

    Menu

    5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 34,600Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 50718 / DOSAGE - INJECTABLE, LIPOSOMAL;INJECTION - 50MG/25ML (2MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    doxorubicin hydrochloride(UNII: 82F2G7BL4E)
    (doxorubicin - UNII:80168379AG)     		doxorubicin hydrochloride2mg in 1

    Inactive Ingredients

    Ingredient Name
    BluePoint Laboratories
    Janssen Products, LP
    ammonium sulfate(SU46BAM238)
    CHOLESTEROL(97C5T2UQ7J)
    HISTIDINE(4QD397987E)
    hydrochloric acid(QTT17582CB)
    hydrogenated soybean lecithin(H1109Z9J4N)
    SODIUM HYDROXIDE(55X04QC32I)
    SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(3L6NN8ZZKU)
    SUCROSE(C151H8M554)